Antidepressants as analgesics: an overview of central and peripheral mechanisms of action.
J Sawynok, MJ Esser, AR Reid - Journal of Psychiatry and …, 2001 - ncbi.nlm.nih.gov
… Data for amitriptyline, desipramine and fluoxetine are from Esser and Sawynok9 and Sawynok
… Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptiveaction of amitriptyline in the rat …
… Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptiveaction of amitriptyline in the rat …
Memory T cells and vaccines
MT Esser, RD Marchese, LS Kierstead, LG Tussey… - Vaccine, 2003 - Elsevier
T lymphocytes play a central role in the generation of a protective immune response in many
microbial infections. After immunization, dendritic cells take up microbial antigens and traffic …
microbial infections. After immunization, dendritic cells take up microbial antigens and traffic …
[HTML][HTML] Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19
…, K Streicher, MN Pangalos, MT Esser - … England Journal of …, 2022 - Mass Medical Soc
Background The monoclonal-antibody combination AZD7442 is composed of tixagevimab
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …
[HTML][HTML] Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
…, R Railkar, MT Esser, HL Sings, M Nelson… - … England Journal of …, 2007 - Mass Medical Soc
Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic quadrivalent
vaccine in preventing anogenital diseases associated with human papillomavirus (HPV…
vaccine in preventing anogenital diseases associated with human papillomavirus (HPV…
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo …
…, R Railkar, FJ Taddeo, KU Jansen, MT Esser… - The lancet …, 2005 - thelancet.com
Background A randomised double-blind placebo-controlled phase II study was done to
assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (…
assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (…
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a …
…, OM Bautista, MT Esser, HL Sings, M Nelson… - The Lancet, 2007 - thelancet.com
Background Vulval and vaginal cancers among younger women are often related to infection
with human papillomavirus (HPV). These cancers are preceded by high-grade vulval …
with human papillomavirus (HPV). These cancers are preceded by high-grade vulval …
[HTML][HTML] High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
…, R Railkar, FJ Taddeo, J Bryan, MT Esser… - British Journal of …, 2006 - nature.com
Human papillomavirus (HPV) causes cervical, vulvar, and vaginal cancers, precancerous
dysplasia, and genital warts. We report data for the longest efficacy evaluation to date of a …
dysplasia, and genital warts. We report data for the longest efficacy evaluation to date of a …
[HTML][HTML] Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
…, H Bright, YM Loo, PM McTamney, MT Esser… - Nature …, 2021 - nature.com
Understanding the molecular basis for immune recognition of SARS-CoV-2 spike glycoprotein
antigenic sites will inform the development of improved therapeutics. We determined the …
antigenic sites will inform the development of improved therapeutics. We determined the …
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
…, J Yu, L Lupinacci, R Railkar, R Marchese, MT Esser… - Vaccine, 2006 - Elsevier
Human papillomavirus (HPV) infection causes cervical cancer and genital warts. Young
women (1106) were randomized to receive one of three formulations of a quadrivalent HPV (…
women (1106) were randomized to receive one of three formulations of a quadrivalent HPV (…
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double …
…, V Alagappan, MN Pangalos, MT Esser… - The Lancet …, 2022 - thelancet.com
Background Early intramuscular administration of SARS-CoV-2-neutralising monoclonal
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …